[Locoregional use of TNF (tumor necrosis factor) in the treatment of malignant melanoma].
Institut Jules-Bordet, Bruxelles, Belgique.
F
F
Lejeune
D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008545:Melanoma / Q000628:therapy*; D008558:Melphalan / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000627:therapeutic use*
D014409:Tumor Necrosis Factor-alpha; D007372:Interferons; D008558:Melphalan
Utilisation locorégionale du TNF (tumor necrosis factor) dans le traitement du mélanome malin.